XORTX Therapeutics Inc (XRTX) — Strategic Asset Allocation Index
XORTX Therapeutics Inc (XRTX) has a Strategic Asset Allocation Index of 1.3% as of December 2022. Strategic assets (PP&E of CA$125.53K plus long-term investments of CA$-) total CA$125.53K, measured against net assets of CA$9.47 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
XORTX Therapeutics Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how XORTX Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2018 to 2022. As of December 2022, the index stands at 1.3%, representing strategic assets of CA$125.53K against net assets of CA$9.47 Million CAD. Explore XRTX cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for XORTX Therapeutics Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for XORTX Therapeutics Inc from 2018 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see XRTX market cap overview.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.8% | CA$125.53K | CA$125.53K | CA$- | CA$6.97 Million | ▲ +1.6 pp |
| 2018 | 0.2% | CA$731.00 | CA$731.00 | CA$- | CA$321.54K | — |